There is a continued national supply issue with some medications, particularly hormone replacement therapy medication Utrogestan®.

Utrogestan®, a type of HRT used to treat menopausal symptoms, is expected to be in intermittent supply until late 2023.

As stock is limited when pharmacies can obtain the product they have been instructed to only dispense 2 months supply as regulated by the Government. However, many patients are finding repeated out of stocks in their local pharmacist due to increased demand and restricted supply.

• The Practice cannot provide a further prescription for a greater supply. 

• Your pharmacist does not contact the Practice to inform us of their stock levels.

What other help is available ?

There is only one tablet alternative available at present which is not covered by the HRT certificate.

Another option would be to consider discussing with the GP or Nurse about having a coil fitted or to discuss with a GP if other formulations would be appropriate.

Take your prescription to another chemist. The shortages are exacerbated by limited communications across the pharmacy sector and a restricted supply chain.

We would advise patients to try at least three pharmacies before contacting the Practice. It is our experience that at any given time, usually one of the local pharmacists has stock.